ICU Medical (NASDAQ:ICUI) Upgraded by Wall Street Zen to “Buy” Rating

Wall Street Zen upgraded shares of ICU Medical (NASDAQ:ICUI) from a hold rating to a buy rating in a research report released on Sunday morning.

A number of other research firms have also commented on ICUI. Piper Sandler raised their price objective on shares of ICU Medical from $153.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. KeyCorp increased their price target on ICU Medical from $173.00 to $175.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of ICU Medical in a research note on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $175.67.

ICU Medical Stock Performance

ICUI stock opened at $144.90 on Friday. The company has a 50-day simple moving average of $148.95 and a 200 day simple moving average of $135.21. The company has a market capitalization of $3.58 billion, a P/E ratio of -467.40 and a beta of 0.79. The company has a quick ratio of 1.19, a current ratio of 2.45 and a debt-to-equity ratio of 0.62. ICU Medical has a fifty-two week low of $107.00 and a fifty-two week high of $165.17.

Hedge Funds Weigh In On ICU Medical

Hedge funds have recently modified their holdings of the stock. Hilton Head Capital Partners LLC purchased a new stake in shares of ICU Medical during the fourth quarter valued at $32,000. Cullen Frost Bankers Inc. acquired a new stake in ICU Medical during the 2nd quarter worth about $38,000. SJS Investment Consulting Inc. lifted its stake in ICU Medical by 41,000.0% during the third quarter. SJS Investment Consulting Inc. now owns 411 shares of the medical instruments supplier’s stock valued at $49,000 after buying an additional 410 shares in the last quarter. Covestor Ltd lifted its stake in ICU Medical by 70.7% during the third quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier’s stock valued at $68,000 after buying an additional 236 shares in the last quarter. Finally, Strs Ohio boosted its holdings in shares of ICU Medical by 60.0% in the fourth quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock worth $114,000 after buying an additional 300 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.